limit
inform
avail
transmiss
spread
influenza
viru
pig
popul
differ
immun
status
studi
assess
differ
transmiss
pattern
quantifi
spread
tripl
reassort
influenza
viru
vaccin
pig
popul
estim
reproduct
ratio
r
infect
ie
number
secondari
infect
caus
infecti
individu
use
determinist
susceptibleinfectiousrecov
sir
model
fit
experiment
data
one
hundr
ten
pig
distribut
ten
isol
room
follow
nonvaccin
nv
ii
vaccin
heterolog
vaccin
iii
vaccin
homolog
inactiv
vaccin
ho
studi
run
multipl
replic
replic
infect
nonvaccin
pig
place
contact
pig
two
week
transmiss
influenza
evalu
daili
analyz
individu
nasal
swab
rtpcr
statist
signific
differ
r
estim
observ
vaccin
nonvaccin
pig
p
statist
signific
reduct
transmiss
observ
vaccin
group
r
ci
ho
group
respect
compar
r
valu
nv
pig
p
transmiss
group
delay
variabl
compar
nv
group
transmiss
could
detect
ho
group
result
studi
indic
influenza
vaccin
use
decreas
suscept
influenza
infect
decreas
influenza
transmiss
influenza
pig
highli
contagi
viral
diseas
respiratori
tract
influenza
current
endem
swine
popul
around
world
viru
tend
spread
easili
suscept
popul
mani
factor
contribut
sever
diseas
includ
age
viral
strain
concurr
infect
immun
statu
anim
detect
new
influenza
subtyp
last
decad
ie
tripl
reassort
virus
pig
recent
appear
pandem
human
anim
health
offici
paid
greater
attent
flu
pig
due
role
pig
play
interspeci
transmiss
control
influenza
pig
often
accomplish
use
vaccin
inactiv
licens
commerci
vaccin
autogen
licens
inactiv
vaccin
commonli
use
pig
commerci
vaccin
confer
protect
flu
infect
diseas
present
often
protect
partial
commerci
vaccin
usual
includ
one
isol
repres
strain
region
may
alway
confer
protect
isol
infect
specif
farm
popul
hand
autogen
vaccin
may
prepar
isol
isol
recov
specif
product
system
restrict
use
system
vaccin
gain
popular
us
past
year
although
vaccin
result
reduct
clinic
sign
viru
shed
limit
inform
avail
effect
vaccin
popul
suscept
spread
infect
vaccin
may
prevent
transmiss
speci
transmiss
experi
mathemat
model
use
quantifi
vaccineinduc
reduct
spread
mycoplasma
hyopneumonia
pseudorabi
viru
classic
swine
fever
actinobacillu
pleuropneumonia
encephalomyocard
viru
emcv
foot
mouth
diseas
fmdv
porcin
reproduct
respiratori
syndrom
viru
prrsv
hepat
e
viru
porcin
circoviru
type
pig
order
quantifi
transmiss
pathogen
key
paramet
reproduct
ratio
r
infect
defin
averag
number
secondari
case
caus
infecti
individu
popul
entir
infecti
period
r
greater
infect
spread
popul
r
less
infect
die
within
popul
estim
r
provid
import
inform
potenti
transmiss
infect
dynam
infect
popul
level
impact
diseas
control
strategi
reproduct
ratio
assess
influenza
viru
human
bird
hors
r
report
influenza
viru
pig
studi
determinist
sir
model
susceptibleinfectedrecoveredremov
use
compar
transmiss
paramet
nonvaccin
popul
vaccin
popul
pig
follow
introduct
nonvaccin
infect
pig
tripl
reassort
influenza
viru
introduct
infect
pig
popul
one
primari
mode
influenza
viru
transmiss
field
set
studi
mimic
similar
scenario
specif
aim
assess
effect
vaccin
pig
suscept
infect
sinc
differ
vaccin
contain
inactiv
virus
either
homolog
heterolog
challeng
viru
use
studi
addit
comparison
could
made
vaccin
type
result
studi
provid
relev
inform
use
vaccin
control
influenza
transmiss
highlight
implic
partial
protect
may
transmiss
dynam
risk
infect
one
hundr
ten
threeweekold
crossbr
pig
specificpathogenfre
spf
herd
obtain
pig
free
infect
influenza
viru
prr
viru
hyopneumonia
sow
vaccin
influenza
viru
piglet
screen
herd
origin
influenza
antibodi
use
hemagglutin
inhibit
hi
test
influenza
multiscreen
enzym
link
immunosorb
assay
elisa
idexx
ai
multisscreen
ab
test
kit
idexx
lab
westbrook
usa
prior
start
studi
pig
randomli
distribut
ten
group
eleven
pig
place
separ
isol
room
locat
univers
minnesota
anim
research
facil
st
paul
mn
usa
pig
assign
differ
treatment
group
follow
nonvaccin
control
nv
ii
vaccin
commerci
licens
heterolog
vaccin
iii
vaccin
experiment
homolog
vaccin
ho
replic
nv
ho
treatment
replic
treatment
space
allow
squar
feet
per
pig
pig
fed
floor
ad
libitum
free
access
water
pig
care
accord
univers
minnesota
iacuc
protocol
number
nasal
swab
blood
sampl
collect
pig
upon
arriv
research
facil
test
real
time
revers
transcriptas
pcr
rtpcr
antibodi
hi
influenza
multiscreen
elisa
pig
also
inject
antibiot
per
label
instruct
order
reduc
bacteri
contamin
prior
start
studi
ceftiofur
crystallin
free
acid
mgkg
bodi
weight
exced
pfizer
anim
health
ny
usa
twentyfour
hour
post
arriv
pig
vaccin
accord
treatment
group
pig
group
receiv
ml
intramuscularli
im
commerci
licens
influenza
vaccin
flusur
xp
pfizer
anim
health
new
york
usa
pig
ho
group
similarli
vaccin
homolog
inactiv
vaccin
contain
viral
isol
challeng
viru
vaccin
repeat
two
week
later
pig
nv
group
inject
ml
steril
salin
solut
im
neck
week
interv
room
pig
design
seeder
left
unvaccin
intratrach
intranas
challeng
influenza
serv
sourc
infect
pig
group
thirteen
day
second
vaccin
nasal
swab
blood
sampl
taken
pig
seeder
pig
move
separ
room
challeng
h
post
challeng
seeder
pig
place
back
room
contact
origin
pen
mate
seeder
piggrouprepl
termin
studi
determin
transmiss
pig
sampl
daili
take
nasal
swab
observ
daili
presenc
clinic
sign
consist
influenza
transmiss
experi
end
day
post
contact
dpc
contact
pig
room
becam
influenza
viru
posit
point
pig
human
euthan
intraven
lethal
dose
pentobarbit
prescrib
amount
mgkg
fatalplu
solut
ml
vortech
pharmaceut
dearborn
mi
usa
tripl
reassort
strain
belong
cluster
use
previou
studi
isol
field
sampl
univers
minnesota
veterinari
diagnost
laboratori
use
challeng
influenza
viru
grown
bulk
quantiti
use
madindarbi
canin
kidney
mdck
cell
use
standard
procedur
prepar
homolog
vaccin
viru
adjust
ha
titer
ml
time
inactiv
addit
formalin
final
concentr
formal
viru
mix
adjuv
mixtur
miner
oil
part
emulsifi
part
equal
volum
span
tween
ratio
sonic
min
heterolog
vaccin
contain
three
distinct
inactiv
influenza
isol
adjuv
aswin
vaccin
strain
belong
group
genet
distinct
challeng
strain
aswinenorth
share
ha
nucleotid
similar
respect
mega
clustal
w
align
nucleotid
kimura
serolog
crossreact
exist
licens
vaccin
strain
challeng
strain
variabl
seeder
pig
infect
intratrach
intranas
total
ml
challeng
viru
titer
tissu
cultur
infecti
dose
tcid
inocul
piglet
sedat
intramuscular
inject
dissoci
anesthet
recommend
dose
mgkg
telazol
fort
dodg
anim
health
fort
dodg
ia
usa
success
inocul
seeder
pig
confirm
posit
influenza
rtpcr
nasal
swab
h
h
post
inocul
viral
isol
titrat
conduct
nasal
swab
h
post
inocul
research
conduct
experiment
infect
wore
respir
mask
protect
glass
glove
perform
procedur
throughout
entir
studi
access
pig
transmiss
experi
consist
ten
suscept
contact
one
infecti
pig
seeder
per
group
initi
infecti
seeder
pig
group
unvaccin
challeng
intratrach
intranas
influenza
viru
pig
consid
infect
infecti
viru
could
detect
rtpcr
nasal
swab
transmiss
experi
end
dpc
seeder
pig
contact
pig
replic
becam
infect
nasal
swab
collect
daili
individu
pig
use
rayontip
swab
applic
stuart
medium
bbl
liquid
stuart
singl
plastic
applicatorbecton
dickinson
com
spark
maryland
usa
sampl
collect
nasal
swab
suspend
ml
minimum
essenti
medium
mem
mediatech
inc
manassa
va
usa
supplement
bovin
serum
albumin
bsa
sigmaaldrich
co
st
loui
mo
usa
prior
process
rtpcr
viral
rna
extract
use
magnet
particl
processor
procedur
viral
rna
isol
kit
appli
biosystem
usa
subsequ
test
use
procedur
provid
usdanvsl
detect
influenza
viru
matrix
gene
rtpcr
minimum
detect
limit
influenza
viru
method
tcid
ml
viru
isol
titrat
perform
nasal
swab
collect
seeder
pig
prior
commingl
tissu
necropsi
mdck
cell
monolay
supernat
show
cytopath
effect
cpe
titrat
use
tenfold
serial
dilut
express
log
tcid
ml
calcul
method
blood
sampl
collect
use
venipuctur
jugular
vein
collect
serum
separ
store
sera
subsequ
analyz
detect
influenza
viru
antibodi
hi
influenza
multiscreen
elisa
hi
test
perform
follow
standard
procedur
sampl
test
hi
challeng
strain
licens
commerci
vaccin
isol
respect
arriv
thirteen
day
second
vaccin
necropsi
addit
sera
test
use
influenza
multiscreen
elisa
follow
manufactur
protocol
influenza
multiscreen
elisa
measur
antibodi
direct
nucleoprotein
np
influenza
virus
necropsi
lung
affect
pneumonia
record
pig
lesion
photograph
sketch
standard
diagram
proport
affect
lung
assess
addit
tissu
lung
lobe
anim
collect
viral
detect
rtpcr
histopatholog
tissu
fix
buffer
formalin
paraffinembed
standard
techniqu
tissu
section
stain
hematoxylin
eosin
examin
microscop
histopatholog
chang
lung
section
examin
bronchiolar
epitheli
chang
peribronchiolar
alveolar
inflamm
lung
section
given
score
reflect
sever
bronchial
epitheli
injuri
base
previous
describ
method
lung
section
score
accord
follow
criteria
signific
lesion
airway
affect
bronchiolar
epitheli
damag
light
peribronchiolar
lymphocyt
cuf
often
accompani
mild
focal
interstiti
pneumonia
airway
affect
often
mild
focal
interstiti
pneumonia
airway
affect
often
interstiti
pneumonia
approxim
airway
affect
usual
signific
interstiti
pneumonia
greater
airway
affect
usual
interstiti
pneumonia
addit
proport
airway
affect
ten
microscop
field
x
magnif
also
record
singl
pathologist
examin
slide
blind
treatment
group
clinic
sign
consist
influenza
record
day
day
post
arriv
day
second
vaccin
daili
dpc
end
experi
dpc
clinic
sign
cough
dyspnea
sneez
nasal
discharg
lethargi
record
period
minobserv
day
room
rectal
temperatur
record
daili
day
prior
commingl
necropsi
temperatur
consid
signific
febril
respons
result
clinic
sign
antibodi
titer
lung
lesion
combin
treatment
group
result
contact
pig
control
homolog
group
contact
pig
heterolog
group
seeder
pig
replic
exclud
analys
compar
antibodi
respons
exposur
necropsi
logtransform
result
hi
antibodi
titer
influenza
multiscreen
elisa
mean
valu
analyz
use
pair
ttest
result
consid
statist
signific
p
clinic
sign
evalu
binomi
respons
presenc
fisher
exact
test
gener
estim
equat
gee
approach
presenc
absenc
clinic
sign
pig
daili
basi
score
respect
analyz
repeat
measur
categor
data
cluster
respons
group
clinic
sign
compar
pig
nv
group
via
odd
ratio
mean
standard
deviat
macroscop
microscop
lung
lesion
score
analyz
use
anova
respons
variabl
statist
signific
effect
p
treatment
group
analyz
pairwis
comparison
use
tukeykram
test
analys
perform
use
sa
sa
system
sa
inst
cari
north
carolina
v
cumul
percentag
contact
pig
infect
per
day
group
compar
kaplanmei
surviv
curv
logrank
test
use
sa
r
sa
system
sa
inst
cari
north
carolina
v
r
develop
core
team
r
languag
environ
statist
comput
r
foundat
statist
comput
vienna
austria
differ
curv
evalu
pair
wise
comparison
use
tukeykram
test
pig
remain
influenza
pcr
neg
end
studi
censor
surviv
curv
also
use
calcul
infecti
period
infecti
period
defin
time
first
last
day
viru
could
detect
nasal
swab
pig
differ
infecti
period
averag
number
day
contact
exposur
first
pig
detect
posit
calcul
use
logrank
test
signific
differ
consid
p
valu
infect
statu
suscept
infecti
recoveredremov
r
determin
daili
basi
pig
transit
pig
state
state
state
r
state
describ
determinist
sir
model
time
interv
interv
two
consecut
sampl
ie
one
day
pig
consid
influenza
viru
detect
rtpcr
nasal
swab
consid
influenza
viru
detect
posit
rtpcr
transmiss
occur
pen
pig
decreas
one
wherea
number
pig
increas
one
transit
occur
accord
probabl
given
infect
transmiss
paramet
denot
rate
randomli
chosen
anim
infecti
contact
interv
estim
transmiss
paramet
gener
linear
model
glm
complementari
loglog
link
function
log
offset
variabl
number
infecti
pigstot
number
pig
use
calcul
estim
transmiss
paramet
day
know
number
suscept
contact
pig
number
infecti
pig
start
period
number
new
infect
appear
end
period
c
total
number
anim
period
n
probabl
pig
becam
infect
number
anim
infect
time
period
e
c
logist
regress
model
provid
direct
estim
transmiss
rate
altern
transform
known
complementari
loglog
calcul
equat
log
log
c
log
log
model
similar
linear
model
follow
log
log
c
x
intercept
coeffici
log
correspond
includ
predictor
x
log
fix
offset
transform
log
transmiss
paramet
could
estim
model
entail
assumpt
suscept
anim
equal
suscept
ii
infect
anim
equal
infecti
iii
infect
pig
pose
independ
risk
infect
suscept
pig
differ
valu
compar
use
chisquar
comparison
differ
consid
statist
signific
p
use
daili
transmiss
rate
infecti
period
contact
infect
pig
reproduct
ratio
r
infect
calcul
replic
group
well
overal
r
group
treatment
replic
combin
statist
signific
differ
r
estim
base
exist
nonoverlap
confid
interv
ci
pig
die
studi
consid
censor
n
becam
analys
carri
sa
sa
system
sa
inst
cari
north
carolina
v
studi
glm
method
use
nv
group
zero
suscept
anim
infect
process
end
situat
effect
vaccin
test
glm
analysi
addit
glm
method
use
analyz
data
heterogen
popul
case
studi
sinc
contact
anim
vaccin
inocul
anim
stochast
sir
model
develop
use
transmiss
recoveri
paramet
obtain
previous
describ
determinist
model
experiment
studi
paramet
list
tabl
stochast
model
initi
number
infecti
suscept
recov
pig
similar
experiment
studi
stochast
model
two
event
could
occur
transmiss
recoveri
r
within
sir
model
r
transmiss
rate
obtain
determinist
model
recoveri
rate
obtain
experiment
studi
invers
infecti
period
rate
transmiss
occur
rate
recoveri
occur
replic
transmiss
occur
experiment
studi
model
separ
simul
use
paramet
obtain
experiment
determinist
model
simul
run
infecti
process
end
final
size
outbreak
could
assess
number
new
case
contact
infect
suscept
individu
observ
simul
given
paramet
list
tabl
assess
replic
initi
number
infecti
suscept
recov
individu
respect
proport
cumul
proport
simul
number
new
case
replic
display
graph
format
direct
method
gillespi
use
model
random
event
transmiss
recoveri
reproduct
ratio
r
replic
reproduct
ratio
r
replic
combin
group
b
c
statist
signific
differ
p
pig
antibodi
influenza
viru
neg
start
studi
tabl
show
level
hi
antibodi
titer
select
flu
strain
prior
exposur
seeder
pig
necropsi
two
week
second
vaccin
homolog
vaccin
induc
robust
hi
titer
challeng
strain
mean
reciproc
titer
group
contrast
group
reciproc
titer
strain
contain
vaccin
mean
reciproc
titer
ho
group
end
experi
hi
titer
challeng
viru
remain
level
ho
group
although
statist
signific
increas
mean
titer
group
observ
p
still
remain
nv
group
pig
seroneg
contact
necropsi
lack
seroconvers
necropsi
like
due
limit
time
infect
necropsi
less
day
mean
influenza
multiscreen
elisa
sn
valu
sd
contact
pig
two
day
prior
exposur
seeder
pig
nv
group
group
ho
group
cutoff
posit
neg
necropsi
mean
sn
respons
nv
ho
group
respect
differ
pair
sampl
nv
group
contact
necropsi
statist
signific
p
figur
seeder
pig
rtpcr
posit
h
post
inocul
prior
comingl
contact
suscept
pig
time
point
viru
titer
nasal
swab
pig
rang
tcdi
ml
contact
pig
nv
group
found
rtpcr
posit
dpc
vaccin
group
pig
group
none
pig
ho
group
posit
rtpcr
tabl
comparison
cumul
percentag
contact
pig
infect
per
day
treatment
group
via
logrank
test
kaplanmei
surviv
analysi
indic
percentag
infect
pig
significantli
higher
nv
group
vaccin
group
p
distribut
overlap
confid
interv
figur
mean
length
infecti
period
ie
time
first
last
day
viru
could
detect
nasal
swab
sd
seeder
contact
pig
shown
tabl
seeder
pig
remain
pcr
posit
averag
day
post
infect
dpi
differ
observ
among
averag
infecti
period
contact
infect
nv
pig
day
day
contact
infect
pig
group
infecti
period
day
shorter
pig
vaccin
vaccin
nv
pig
differ
statist
signific
p
infecti
period
contact
infect
pig
ho
group
zero
addit
averag
number
day
exposur
first
pig
detect
posit
significantli
longer
pig
group
compar
nv
group
p
summari
transmiss
paramet
estim
replic
treatment
group
display
tabl
group
one
pig
human
euthan
dpc
reason
relat
influenza
censor
yield
total
number
contact
pig
replic
nv
group
contact
pig
becam
infect
r
confid
interv
estim
contrast
estim
r
group
ho
group
contact
dpc
necropsi
ie
dpc
control
dpc
vaccin
group
b
statist
signific
differ
p
statist
signific
reduct
r
valu
observ
vaccin
group
p
differ
transmiss
rate
also
statist
signific
nv
group
p
transmiss
ho
vaccin
pig
could
detect
replic
transmiss
group
observ
replic
although
r
two
four
replic
r
statist
signific
howev
statist
signific
differ
transmiss
rate
replic
differ
observ
replic
versu
p
number
new
case
simul
determin
given
paramet
list
tabl
start
valu
r
replic
stochast
model
first
highlight
within
small
popul
larg
outbreak
commonli
occur
given
paramet
nv
replic
figur
least
simul
nv
replic
yield
contact
infect
pig
howev
even
transmiss
recoveri
paramet
gener
r
estim
much
greater
simul
yield
new
case
minor
outbreak
also
occur
approxim
simul
stochast
simul
replic
figur
demonstr
within
small
popul
major
outbreak
rare
number
new
case
gener
low
compar
nv
replic
replic
least
simul
yield
new
case
maximum
simul
yield
new
case
compar
least
simul
nv
replic
distribut
number
new
case
also
variabl
replic
compar
nv
replic
outbreak
either
larg
small
influenzalik
clinic
sign
mild
pig
pig
die
studi
due
influenza
infect
one
contact
pig
group
remov
studi
due
arthriti
odd
pig
display
clinic
sign
fever
lethargi
cough
sneez
nasal
discharg
dyspnea
first
week
exposur
significantli
lower
group
nv
pig
ci
p
macroscop
microscop
lung
lesion
nv
pig
pneumonia
area
lung
consolid
necropsi
mean
sd
lung
lesion
score
thirtyon
pig
group
sixteen
pig
ho
group
degre
lung
consolid
mean
lung
lesion
score
pig
group
significantli
higher
p
mean
pig
ho
group
vs
necropsi
although
macroscop
lung
lesion
nv
group
greater
vaccin
group
comparison
perform
treatment
group
endpoint
lung
lesion
nv
pig
moder
sever
bronchoalveolar
pneumonia
attenu
hyperplasia
moder
number
lymphocyt
admix
macrophag
epithelium
within
intralumin
necrot
cellular
debri
extend
alveolar
space
lung
section
contain
occasion
bacteri
coloni
overal
microscop
lesion
mean
score
necropsi
indic
signific
interstiti
pneumonia
airway
affect
bronchial
epitheli
damag
lung
lesion
heterolog
vaccin
treatment
pig
highli
variabl
rang
absent
sever
lesion
includ
moder
number
lymphocyt
within
hyperplast
epithelium
intralumin
cellular
debri
occasion
bacteri
coloni
one
pig
larg
abscess
one
tissu
section
anoth
pig
aspir
pneumonia
lung
lesion
homolog
vaccin
treatment
pig
absent
minim
lung
pig
minim
moder
epitheli
attenu
hyperplasia
small
number
lymphocyt
within
surround
epithelium
mani
tissu
section
three
group
slight
moder
increas
promin
peribronchiolar
lymphoid
tissu
sever
lung
lesion
score
ho
group
group
indic
differ
sever
lesion
vaccin
group
p
howev
differ
statist
signific
p
vaccin
nonvaccin
group
understand
transmiss
influenza
factor
affect
transmiss
crucial
design
effect
control
strategi
vaccin
far
common
strategi
prevent
flu
infect
howev
littl
known
vaccin
affect
transmiss
within
pig
popul
object
studi
quantifi
spread
tripl
reassort
influenza
viru
popul
pig
calcul
transmiss
paramet
base
outcom
transmiss
experi
assess
effect
vaccin
suscept
influenza
viru
infect
pig
vaccin
either
homolog
heterolog
vaccin
reproduct
ratio
r
expect
averag
number
secondari
infect
caus
typic
infecti
individu
entir
infecti
period
measur
quantifi
transmiss
spread
virus
popul
infect
occur
entir
suscept
popul
reproduct
ratio
name
basic
reproduct
ratio
r
r
greater
infect
spread
popul
r
less
infect
die
within
popul
r
estim
use
assess
effect
vaccin
control
strategi
popul
specif
condit
studi
expect
influenza
viru
spread
quickli
among
non
vaccin
pig
estim
r
popul
high
ci
estim
r
valu
vaccin
group
significantli
differ
valu
nv
group
ho
vaccin
group
r
estim
group
r
rang
overal
estim
ci
howev
r
group
statist
signific
furthermor
statist
signific
differ
could
observ
transmiss
rate
replic
show
variabl
pig
respons
influenza
vaccin
despit
fact
transmiss
significantli
reduc
group
exclud
possibl
outbreak
influenza
could
occur
heterolog
vaccin
popul
evidenc
result
stochast
model
studi
model
estim
present
de
jong
et
al
hand
transmiss
viru
could
detect
ho
vaccin
pig
studi
r
valu
replic
significantli
suggest
infect
spread
popul
vaccin
homolog
vaccin
could
prevent
experi
sir
model
susceptibleinfectiveremov
recov
use
describ
influenza
transmiss
pig
diseas
confer
immun
reinfect
homolog
strain
basic
three
differ
method
use
calcul
infect
paramet
base
upon
experiment
data
gener
linear
model
glm
martingal
estim
maxim
likelihood
estim
base
final
size
outbreak
fs
select
one
three
approach
depend
data
avail
intens
sampl
focus
quantifi
effect
vaccin
suscept
contact
pig
influenza
infect
instead
evalu
effect
infect
vaccin
pig
transmiss
depend
infect
infect
individu
suscept
contact
pig
studi
predict
vaccin
seeder
pig
would
influenc
number
excret
influenza
virus
shown
previou
studi
therefor
would
abl
replic
condit
transmiss
relev
field
situat
introduct
shed
anim
vaccin
popul
common
nevertheless
studi
need
determin
effect
excret
infect
influenza
vaccin
pig
experiment
transmiss
studi
avian
influenza
viru
prrsv
aujeszki
diseas
abl
correl
amount
viru
excret
infect
pig
increas
valu
transmiss
paramet
studi
initi
infect
similar
group
due
use
unvaccin
experiment
inocul
seeder
pig
experiment
condit
also
statist
signific
differ
observ
tcid
valu
time
exposur
contact
pig
infecti
period
similar
seeder
pig
therefor
differ
transmiss
group
attribut
decreas
suscept
contact
pig
becom
infect
length
ip
group
infecti
period
one
day
shorter
group
nv
group
could
play
role
valu
r
account
differ
observ
replic
overal
detect
influenza
viru
vaccin
popul
last
longer
nv
popul
also
highlight
role
partial
immun
popul
potenti
sustain
reservoir
influenza
infect
r
influenza
viru
estim
previous
chicken
hors
r
estim
avian
influenza
strain
respect
equin
influenza
strain
studi
r
reduc
chicken
vaccin
inactiv
strain
also
chicken
vaccin
two
inactiv
strain
avian
flu
viru
contrast
recent
studi
report
transmiss
affect
vaccin
broiler
chicken
suggest
might
due
interfer
matern
immun
hors
r
reduc
homolog
vaccin
popul
heterolog
vaccin
popul
knowledg
first
studi
calcul
r
influenza
viru
pig
r
within
report
valu
influenza
speci
addit
result
studi
also
suggest
vaccin
pig
use
reduc
level
suscept
although
degre
viru
spread
still
take
place
popul
immun
reproduct
ratio
estim
obtain
determinist
model
provid
use
threshold
valu
rate
stochast
model
allow
one
investig
estim
outcom
probabl
number
new
case
stochast
import
consid
deal
small
popul
popul
reflect
experiment
studi
stochast
model
also
use
complement
determinist
model
assess
whether
major
infer
compar
across
two
differ
approach
determinist
model
r
estim
nv
replic
rang
therefor
follow
introduct
one
typic
infect
pig
complet
suscept
popul
secondari
case
expect
due
typic
infecti
pig
entir
infecti
period
nv
stochast
model
reiter
estim
show
major
influenza
viru
outbreak
like
occur
small
popul
follow
introduct
one
infect
pig
distribut
new
case
also
similar
across
replic
nv
group
either
small
larg
outbreak
occur
initi
infect
pig
transmit
infect
suscept
pig
infect
chain
proceed
nearli
anim
infect
simul
like
describ
high
morbid
rate
observ
field
set
suscept
anim
nv
stochast
model
also
clearli
show
new
case
minor
outbreak
also
occur
albeit
low
frequenc
similar
popul
even
r
valu
high
r
estim
obtain
determinist
model
group
lower
nv
group
rang
result
stochast
model
reiter
valu
obtain
determinist
model
replic
lower
r
valu
yield
higher
proport
stochast
simul
new
case
find
expect
lower
r
estim
equat
fewer
secondari
case
due
typic
infecti
individu
entir
infecti
period
replic
proport
simul
major
outbreak
low
contrari
new
case
observ
least
simul
regardless
replic
proport
simul
new
case
observ
greatest
replic
r
valu
lower
impact
vaccin
assess
small
popul
result
stochast
model
compar
nv
group
small
popul
introduct
influenza
viru
infect
pig
result
major
outbreak
infect
suscept
anim
greater
simul
follow
vaccin
vaccin
small
popul
proport
simul
suscept
anim
becom
infect
follow
introduct
infect
pig
small
howev
presenc
immun
transmiss
influenza
viru
suscept
anim
occur
prevent
high
simul
seen
replic
antibodi
hemagglutinin
protein
correl
strong
immun
respons
influenza
decreas
likelihood
becom
infect
howev
level
protect
hi
titer
viru
replic
easili
establish
due
continu
antigen
drift
viru
due
reciproc
hi
titer
alon
may
guarante
immun
predict
suscept
kyriaki
et
al
experiment
studi
pig
vaccin
four
differ
commerci
vaccin
challeng
heterolog
field
isol
found
pig
reciproc
hi
antibodi
titer
field
strain
virologicali
protect
van
reeth
et
al
determin
complet
virolog
protect
heterolog
strain
hi
titer
high
requir
studi
viral
protect
refer
individu
viru
titer
lung
lobe
day
post
experiment
challeng
relat
clinic
sign
transmiss
viru
studi
two
week
second
vaccin
exposur
seeder
pig
pig
ho
group
geometr
mean
hi
titer
geometr
mean
group
challeng
strain
maximum
reciproc
titer
challeng
viru
demonstr
low
serolog
crossreact
antiserum
induc
heterolog
vaccin
nine
forti
pig
group
reciproc
hi
titer
greater
challeng
strain
exposur
seeder
pig
two
pig
becam
infect
seven
remain
uninfect
durat
studi
therefor
hi
titer
challeng
strain
pig
abl
predict
infecti
statu
pig
end
studi
low
immunogen
challeng
viru
pig
expect
agreement
studi
pig
vaccin
licens
inactiv
vaccin
becam
infect
challeng
heterolog
influenza
virus
end
studi
pig
seroconvert
challeng
strain
shed
viru
eighteen
pig
group
posit
hi
titer
challeng
strain
necropsi
pig
hi
titer
viru
could
detect
nasal
swab
sampl
lack
detect
could
due
protect
lack
viru
replic
due
amount
viru
excret
detect
level
anoth
point
consider
definit
regard
homolog
heterolog
relat
ha
genet
antigen
cluster
challeng
strain
belong
beta
influenza
cluster
strain
commerci
vaccin
gamma
delta
cluster
share
ha
nucleotid
similar
respect
challeng
strain
although
known
crossreact
may
exist
cluster
consid
limit
like
influenc
degre
infect
therefor
outcom
transmiss
dynam
may
also
influenc
degre
crossreact
cluster
studi
need
determin
extent
differ
transmiss
could
also
due
differ
vaccin
efficaci
due
differ
antigen
concentr
adjuv
use
factor
studi
equin
strain
document
crucial
role
vaccin
dose
adjuv
protect
heterolog
challeng
studi
amount
antigen
standard
homolog
heterolog
vaccin
group
vaccin
commerci
licens
vaccin
inform
antigen
content
avail
improv
protect
provid
autogen
vaccin
like
due
prepar
viru
strain
homolog
challeng
viru
well
document
strainspecif
antibodi
effect
cross
reactiveantibodi
confer
protect
flu
infect
studi
pig
receiv
homolog
vaccin
detect
viru
nasal
secret
robust
antibodi
respons
challeng
viru
significantli
lower
macroscop
lung
lesion
score
compar
pig
receiv
licens
heterolog
vaccin
differ
microscop
lesion
vaccin
group
histopatholog
nv
group
compat
previou
influenza
infect
histopatholog
ho
group
indic
although
lesion
absent
homolog
pig
pig
minim
bronchiolar
lesion
consist
recoveri
influenza
infect
despit
fact
rtpcr
result
ho
group
neg
conclus
ruleout
possibl
infect
took
place
pig
ho
group
infect
taken
place
infect
appear
limit
lower
respiratori
tract
viru
could
detect
method
use
studi
addit
clinic
sign
rel
mild
infect
pig
similar
report
previou
studi
use
influenza
viru
studi
vaccin
decreas
presenc
diseas
impact
influenza
infect
importantli
studi
highlight
potenti
influenza
transmiss
despit
reduct
obviou
clinic
sign
partial
immun
popul
recommend
use
surveil
program
base
clinic
sign
particular
partial
immun
popul
moreov
discuss
previous
viru
remain
extend
period
time
partial
immun
popul
silent
spread
influenza
viru
lead
higher
probabl
transmiss
herd
peopl
also
shown
savil
et
al
overal
import
consider
regard
inactiv
vaccin
whether
virus
replic
transmit
presenc
degre
immun
condit
viru
escap
variant
aris
lead
antigen
drift
loss
vaccin
efficaci
emerg
new
strain
subclin
infect
viru
shed
occur
vaccin
anim
particularli
mismatch
vaccin
field
viru
strain
studi
viru
replic
transmiss
observ
vaccin
group
suggest
potenti
role
vaccin
establish
enzoot
infect
predisposit
viru
chang
howev
whether
viru
chang
happen
result
vaccin
immun
pressur
beyond
scope
studi
warrant
futur
studi
limit
studi
inocul
dose
seeder
pig
could
lead
higher
shed
influenza
subsequ
overestim
r
compar
condit
occur
field
studi
also
limit
one
licens
vaccin
one
autogen
vaccin
result
reflect
transmiss
singl
flu
strain
limit
popul
therefor
transmiss
paramet
popul
vaccin
other
vaccin
infect
differ
strain
would
need
evalu
assess
influenza
transmiss
pattern
pig
addit
start
condit
studi
r
design
reflect
potenti
field
scenario
infect
pig
introduc
pen
suscept
vaccin
pig
paramet
estim
studi
may
accur
reflect
transmiss
paramet
differ
popul
structur
set
conclus
transmiss
paramet
estim
deriv
studi
use
understand
influenza
transmiss
dynam
immun
swine
popul
studi
transmiss
contact
pig
significantli
reduc
vaccin
could
complet
prevent
heterolog
vaccin
use
viru
transmiss
replic
delay
variabl
heterolog
vaccin
group
hand
transmiss
could
detect
homolog
vaccin
pig
heterolog
vaccin
group
activ
transmiss
took
place
even
absenc
clinic
sign
presenc
immun
result
silent
spread
influenza
viru
may
contribut
establish
enzoot
infect
popul
increas
probabl
transmiss
herd
popul
turn
also
risk
interspeci
transmiss
zoonot
infect
result
present
studi
support
field
observ
regard
variabl
observ
influenza
vaccin
affect
transmiss
spread
influenza
viru
